<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>narsil's Comments</title>
    <description>narsil's Comments RSS Syndication from SeekingAlpha.com</description>
    <link>http://seekingalpha.com/user/4984741/comments</link>
    <item>
      <title>Arena Is Still A Great Short</title>
      <link>http://seekingalpha.com/article/1457831/comments?source=feed#comment-19193831</link>
      <guid isPermaLink="false">19193831</guid>
      <content>
        <![CDATA[If ARNA is &quot;a great short&quot; how come I've never been able to borrow shares from any of the major brokerages to short it?]]>
      </content>
      <pubDate>Fri, 24 May 2013 01:13:32 -0400</pubDate>
      <description>
        <![CDATA[If ARNA is &quot;a great short&quot; how come I've never been able to borrow shares from any of the major brokerages to short it?]]>
      </description>
    </item>
    <item>
      <title>Arena Pharmaceuticals - Out To Launch Or Out To Lunch?</title>
      <link>http://seekingalpha.com/article/1452341/comments?source=feed#comment-19114771</link>
      <guid isPermaLink="false">19114771</guid>
      <content>
        <![CDATA[Spencer, what's the cost basis on your ARNA shares? Being long at $10 or $1 per share would totally alter one's outlook here.]]>
      </content>
      <pubDate>Wed, 22 May 2013 09:59:09 -0400</pubDate>
      <description>
        <![CDATA[Spencer, what's the cost basis on your ARNA shares? Being long at $10 or $1 per share would totally alter one's outlook here.]]>
      </description>
    </item>
    <item>
      <title>Arena Pharmaceuticals - Out To Launch Or Out To Lunch?</title>
      <link>http://seekingalpha.com/article/1452341/comments?source=feed#comment-19110291</link>
      <guid isPermaLink="false">19110291</guid>
      <content>
        <![CDATA[I can't find any news of that insider transaction, link it please]]>
      </content>
      <pubDate>Wed, 22 May 2013 08:51:44 -0400</pubDate>
      <description>
        <![CDATA[I can't find any news of that insider transaction, link it please]]>
      </description>
    </item>
    <item>
      <title>Schadenfreude Suits Me Just Fine</title>
      <link>http://seekingalpha.com/article/1378091/comments?source=feed#comment-18180231</link>
      <guid isPermaLink="false">18180231</guid>
      <content>
        <![CDATA[Selling FB puts sounds good but without some rational reasons it's not worth publishing an article. For the reader's edification please explain your rationale as to why FB will drop in the coming week other than a hunch.]]>
      </content>
      <pubDate>Sat, 27 Apr 2013 20:58:44 -0400</pubDate>
      <description>
        <![CDATA[Selling FB puts sounds good but without some rational reasons it's not worth publishing an article. For the reader's edification please explain your rationale as to why FB will drop in the coming week other than a hunch.]]>
      </description>
    </item>
    <item>
      <title>3 Reasons To Short Facebook</title>
      <link>http://seekingalpha.com/article/1376731/comments?source=feed#comment-18147411</link>
      <guid isPermaLink="false">18147411</guid>
      <content>
        <![CDATA[I forgot to ask the obligatory question, why don't you initiate a short position in FB if your analysis is as good as you claim to believe?]]>
      </content>
      <pubDate>Fri, 26 Apr 2013 15:21:35 -0400</pubDate>
      <description>
        <![CDATA[I forgot to ask the obligatory question, why don't you initiate a short position in FB if your analysis is as good as you claim to believe?]]>
      </description>
    </item>
    <item>
      <title>3 Reasons To Short Facebook</title>
      <link>http://seekingalpha.com/article/1376731/comments?source=feed#comment-18146411</link>
      <guid isPermaLink="false">18146411</guid>
      <content>
        <![CDATA[The majority of Facebook's revenue is from advertising, not from the FB pay services mentioned in this article. The ad-based revenue from FB looks promising for Q1.<br/><br/>LNKD has a forward P/E of 90, FB has a forward P/E of 35. FB has more growth potential and is undervalued based on future earnings. LNKD took off after last quarter's earnings, FB could do the same with good earnings.<br/><br/>It's not a good strategy to short  FB ahead of earnings, definitely not at the $26-$27 level. With the increase in short interest in this stock, and with the good chance of an earnings beat, the smart contrarian move is going long on Facebook  for a possible  short squeeze after earnings.]]>
      </content>
      <pubDate>Fri, 26 Apr 2013 15:04:36 -0400</pubDate>
      <description>
        <![CDATA[The majority of Facebook's revenue is from advertising, not from the FB pay services mentioned in this article. The ad-based revenue from FB looks promising for Q1.<br/><br/>LNKD has a forward P/E of 90, FB has a forward P/E of 35. FB has more growth potential and is undervalued based on future earnings. LNKD took off after last quarter's earnings, FB could do the same with good earnings.<br/><br/>It's not a good strategy to short  FB ahead of earnings, definitely not at the $26-$27 level. With the increase in short interest in this stock, and with the good chance of an earnings beat, the smart contrarian move is going long on Facebook  for a possible  short squeeze after earnings.]]>
      </description>
    </item>
    <item>
      <title>Watch Out AT&amp;T: Facebook Could Take Over The Smartphone</title>
      <link>http://seekingalpha.com/article/1352381/comments?source=feed#comment-17880201</link>
      <guid isPermaLink="false">17880201</guid>
      <content>
        <![CDATA[How was the $40 IPO accurate? You contradict yourself with the sentences you write after that statement.]]>
      </content>
      <pubDate>Sat, 20 Apr 2013 16:42:59 -0400</pubDate>
      <description>
        <![CDATA[How was the $40 IPO accurate? You contradict yourself with the sentences you write after that statement.]]>
      </description>
    </item>
    <item>
      <title>Watch Out AT&amp;T: Facebook Could Take Over The Smartphone</title>
      <link>http://seekingalpha.com/article/1352381/comments?source=feed#comment-17828921</link>
      <guid isPermaLink="false">17828921</guid>
      <content>
        <![CDATA[&quot;Insiders certainly seem to be on board.&quot;<br/><br/>Check out the insider transactions for Facebook. I've never seen a stock with so many large insider sales starting at the inflated IPO price of $38.<br/><br/>&quot;Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.&quot;<br/><br/>No downside to FB stock mentioned in this article, it's odd you aren't a stockholder in FB.]]>
      </content>
      <pubDate>Fri, 19 Apr 2013 09:30:06 -0400</pubDate>
      <description>
        <![CDATA[&quot;Insiders certainly seem to be on board.&quot;<br/><br/>Check out the insider transactions for Facebook. I've never seen a stock with so many large insider sales starting at the inflated IPO price of $38.<br/><br/>&quot;Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.&quot;<br/><br/>No downside to FB stock mentioned in this article, it's odd you aren't a stockholder in FB.]]>
      </description>
    </item>
    <item>
      <title>Watch Out AT&amp;T: Facebook Could Take Over The Smartphone</title>
      <link>http://seekingalpha.com/article/1352381/comments?source=feed#comment-17821061</link>
      <guid isPermaLink="false">17821061</guid>
      <content>
        <![CDATA[&quot;Facebook shares have been climbing since November&quot;<br/><br/>Deceptively worded. FB stock has been falling since January. ]]>
      </content>
      <pubDate>Fri, 19 Apr 2013 01:07:17 -0400</pubDate>
      <description>
        <![CDATA[&quot;Facebook shares have been climbing since November&quot;<br/><br/>Deceptively worded. FB stock has been falling since January. ]]>
      </description>
    </item>
    <item>
      <title>Signs Of A Correction</title>
      <link>http://seekingalpha.com/article/1350401/comments?source=feed#comment-17785181</link>
      <guid isPermaLink="false">17785181</guid>
      <content>
        <![CDATA[If today and tomorrow are big sell-off days the correction could be over by this week.]]>
      </content>
      <pubDate>Thu, 18 Apr 2013 10:27:46 -0400</pubDate>
      <description>
        <![CDATA[If today and tomorrow are big sell-off days the correction could be over by this week.]]>
      </description>
    </item>
    <item>
      <title>Arena Short Interest Remains Interesting</title>
      <link>http://seekingalpha.com/article/1313651/comments?source=feed#comment-17126761</link>
      <guid isPermaLink="false">17126761</guid>
      <content>
        <![CDATA[I am skeptical of any Seekingalpha author's agenda, especially with biotechs. SA has a history of allowing shady authors to manipulate stock prices for their own ends at the reader's and retail investor's expense. ]]>
      </content>
      <pubDate>Tue, 02 Apr 2013 15:30:29 -0400</pubDate>
      <description>
        <![CDATA[I am skeptical of any Seekingalpha author's agenda, especially with biotechs. SA has a history of allowing shady authors to manipulate stock prices for their own ends at the reader's and retail investor's expense. ]]>
      </description>
    </item>
    <item>
      <title>Arena Short Interest Remains Interesting</title>
      <link>http://seekingalpha.com/article/1313651/comments?source=feed#comment-17112391</link>
      <guid isPermaLink="false">17112391</guid>
      <content>
        <![CDATA[Not much new in this article. The options volume for May suggest ARNA is going to stay around 8-9, I think that's most likely considering how the stock's been moving. How long after the first month of sales will it take for the sales results to be made public?]]>
      </content>
      <pubDate>Tue, 02 Apr 2013 11:00:14 -0400</pubDate>
      <description>
        <![CDATA[Not much new in this article. The options volume for May suggest ARNA is going to stay around 8-9, I think that's most likely considering how the stock's been moving. How long after the first month of sales will it take for the sales results to be made public?]]>
      </description>
    </item>
    <item>
      <title>Playing Arena's Launch Of Belviq</title>
      <link>http://seekingalpha.com/article/1307831/comments?source=feed#comment-17020401</link>
      <guid isPermaLink="false">17020401</guid>
      <content>
        <![CDATA[I just looked this up, last July VVUS slowly sold off after getting FDA approval for Qysmia. Belviq approval could have a similar result. That should have been researched and mentioned in this article.]]>
      </content>
      <pubDate>Sat, 30 Mar 2013 15:56:45 -0400</pubDate>
      <description>
        <![CDATA[I just looked this up, last July VVUS slowly sold off after getting FDA approval for Qysmia. Belviq approval could have a similar result. That should have been researched and mentioned in this article.]]>
      </description>
    </item>
    <item>
      <title>BlackBerry: Ignore The Noise And Take Advantage Of The Volatility</title>
      <link>http://seekingalpha.com/article/1296701/comments?source=feed#comment-16717471</link>
      <guid isPermaLink="false">16717471</guid>
      <content>
        <![CDATA[This is a very high-risk trade, BBRY could very well retreat to the 200 day MA around 11 after earnings and/or a market dip.]]>
      </content>
      <pubDate>Sun, 24 Mar 2013 01:41:33 -0400</pubDate>
      <description>
        <![CDATA[This is a very high-risk trade, BBRY could very well retreat to the 200 day MA around 11 after earnings and/or a market dip.]]>
      </description>
    </item>
    <item>
      <title>Arena Short Interest As Launch Of Belviq Approaches</title>
      <link>http://seekingalpha.com/article/1232131/comments?source=feed#comment-15649141</link>
      <guid isPermaLink="false">15649141</guid>
      <content>
        <![CDATA[You just made a good point, Healthythoughts, perhaps Belviq will be used off-label as a mild depression treatment while being prescribed for obesity. There's a big market for depressed overeaters.]]>
      </content>
      <pubDate>Thu, 28 Feb 2013 15:06:13 -0500</pubDate>
      <description>
        <![CDATA[You just made a good point, Healthythoughts, perhaps Belviq will be used off-label as a mild depression treatment while being prescribed for obesity. There's a big market for depressed overeaters.]]>
      </description>
    </item>
    <item>
      <title>It's Now Time For Vivus Investors To Watch Arena Numbers</title>
      <link>http://seekingalpha.com/article/1233271/comments?source=feed#comment-15638121</link>
      <guid isPermaLink="false">15638121</guid>
      <content>
        <![CDATA[Why shouldn't someone fifty pounds overweight be advised  to use Belviq to help lose weight? Most obesity is also caused by lifestyle, so those obese people who will be prescribed Belviq are also using this as an edge, whereas they could just consume 1500 calories a day and exercise and all of them would lose weight. Science is showing being overweight, not just obese, leads to many serious health conditions.]]>
      </content>
      <pubDate>Thu, 28 Feb 2013 12:14:03 -0500</pubDate>
      <description>
        <![CDATA[Why shouldn't someone fifty pounds overweight be advised  to use Belviq to help lose weight? Most obesity is also caused by lifestyle, so those obese people who will be prescribed Belviq are also using this as an edge, whereas they could just consume 1500 calories a day and exercise and all of them would lose weight. Science is showing being overweight, not just obese, leads to many serious health conditions.]]>
      </description>
    </item>
    <item>
      <title>Dan Loeb's Position In Herbalife</title>
      <link>http://seekingalpha.com/article/1223571/comments?source=feed#comment-15521151</link>
      <guid isPermaLink="false">15521151</guid>
      <content>
        <![CDATA[This article should be deleted, agreed.]]>
      </content>
      <pubDate>Tue, 26 Feb 2013 09:47:48 -0500</pubDate>
      <description>
        <![CDATA[This article should be deleted, agreed.]]>
      </description>
    </item>
    <item>
      <title>Herbalife: Icahn Cometh - Could The Stock Be Worth $103.93 Per Share?</title>
      <link>http://seekingalpha.com/article/1199681/comments?source=feed#comment-15201421</link>
      <guid isPermaLink="false">15201421</guid>
      <content>
        <![CDATA[Robert, HLF was trading around 50, not the low 40s, in the months before Ackman's short. ]]>
      </content>
      <pubDate>Tue, 19 Feb 2013 10:00:10 -0500</pubDate>
      <description>
        <![CDATA[Robert, HLF was trading around 50, not the low 40s, in the months before Ackman's short. ]]>
      </description>
    </item>
    <item>
      <title>Herbalife: Icahn Cometh - Could The Stock Be Worth $103.93 Per Share?</title>
      <link>http://seekingalpha.com/article/1199681/comments?source=feed#comment-15140671</link>
      <guid isPermaLink="false">15140671</guid>
      <content>
        <![CDATA[Blackswans, Icahn refuted your point in the interview Friday when he said most of the sales growth is in the developing world. The call volume doesn't suggest this is going to fall and stay around $30 in the next few months.]]>
      </content>
      <pubDate>Mon, 18 Feb 2013 00:26:23 -0500</pubDate>
      <description>
        <![CDATA[Blackswans, Icahn refuted your point in the interview Friday when he said most of the sales growth is in the developing world. The call volume doesn't suggest this is going to fall and stay around $30 in the next few months.]]>
      </description>
    </item>
    <item>
      <title>Trade The Extremes In Herbalife</title>
      <link>http://seekingalpha.com/article/1199651/comments?source=feed#comment-15136341</link>
      <guid isPermaLink="false">15136341</guid>
      <content>
        <![CDATA[Actually, in the interview on CNBC Friday Icahn seemed proud he hadn't bought any shares below $30. I don't see many buyers above $50 unless there is unexpected good news.]]>
      </content>
      <pubDate>Sun, 17 Feb 2013 21:20:29 -0500</pubDate>
      <description>
        <![CDATA[Actually, in the interview on CNBC Friday Icahn seemed proud he hadn't bought any shares below $30. I don't see many buyers above $50 unless there is unexpected good news.]]>
      </description>
    </item>
    <item>
      <title>Herbalife: Icahn Cometh - Could The Stock Be Worth $103.93 Per Share?</title>
      <link>http://seekingalpha.com/article/1199681/comments?source=feed#comment-15131261</link>
      <guid isPermaLink="false">15131261</guid>
      <content>
        <![CDATA[The $103.93 a share estimate is a bit misleading because it is based just on the P/E of when HLF was last bought out at. Craig, do you know what the PE Growth rate for five years was when HLF was last bought out at what the PE growth rate for HLF is for the next five years? That would give a closer estimate to a buyout price for the shares, but one should also lower the estimated P/E due to the legal risk HLF is now facing that it wasn't during the last buyout.]]>
      </content>
      <pubDate>Sun, 17 Feb 2013 18:39:04 -0500</pubDate>
      <description>
        <![CDATA[The $103.93 a share estimate is a bit misleading because it is based just on the P/E of when HLF was last bought out at. Craig, do you know what the PE Growth rate for five years was when HLF was last bought out at what the PE growth rate for HLF is for the next five years? That would give a closer estimate to a buyout price for the shares, but one should also lower the estimated P/E due to the legal risk HLF is now facing that it wasn't during the last buyout.]]>
      </description>
    </item>
    <item>
      <title>2 Stocks To Buy, 2 Stocks To Sell</title>
      <link>http://seekingalpha.com/article/1178641/comments?source=feed#comment-15054291</link>
      <guid isPermaLink="false">15054291</guid>
      <content>
        <![CDATA[Why don't you answer my question about FB's intrinsic value then instead of acting like a teenager?]]>
      </content>
      <pubDate>Fri, 15 Feb 2013 14:47:28 -0500</pubDate>
      <description>
        <![CDATA[Why don't you answer my question about FB's intrinsic value then instead of acting like a teenager?]]>
      </description>
    </item>
    <item>
      <title>2 Stocks To Buy, 2 Stocks To Sell</title>
      <link>http://seekingalpha.com/article/1178641/comments?source=feed#comment-15039971</link>
      <guid isPermaLink="false">15039971</guid>
      <content>
        <![CDATA[&quot;The Oxen Group&quot; poster here doesn't have much knowledge to share about the investments mentioned in this article.]]>
      </content>
      <pubDate>Fri, 15 Feb 2013 11:07:20 -0500</pubDate>
      <description>
        <![CDATA[&quot;The Oxen Group&quot; poster here doesn't have much knowledge to share about the investments mentioned in this article.]]>
      </description>
    </item>
    <item>
      <title>2 Stocks To Buy, 2 Stocks To Sell</title>
      <link>http://seekingalpha.com/article/1178641/comments?source=feed#comment-14993481</link>
      <guid isPermaLink="false">14993481</guid>
      <content>
        <![CDATA[What is the intrinsic value of FB?]]>
      </content>
      <pubDate>Thu, 14 Feb 2013 13:34:23 -0500</pubDate>
      <description>
        <![CDATA[What is the intrinsic value of FB?]]>
      </description>
    </item>
    <item>
      <title>Facebook's Rally May Be Over</title>
      <link>http://seekingalpha.com/article/1175391/comments?source=feed#comment-14986471</link>
      <guid isPermaLink="false">14986471</guid>
      <content>
        <![CDATA[Bret, I'm having trouble understanding your logic. How may &quot;Facebook's Rally Be Over&quot; if the fed is pushing everyone into stocks and shorting stocks is not advisable now?]]>
      </content>
      <pubDate>Thu, 14 Feb 2013 11:19:10 -0500</pubDate>
      <description>
        <![CDATA[Bret, I'm having trouble understanding your logic. How may &quot;Facebook's Rally Be Over&quot; if the fed is pushing everyone into stocks and shorting stocks is not advisable now?]]>
      </description>
    </item>
    <item>
      <title>2 Stocks To Buy, 2 Stocks To Sell</title>
      <link>http://seekingalpha.com/article/1178641/comments?source=feed#comment-14978511</link>
      <guid isPermaLink="false">14978511</guid>
      <content>
        <![CDATA[If you believe in these &quot;fundamental conversations&quot; why didn't you take a position in any of the stocks mentioned? FB doesn't just trade on earnings, there is a lot of speculation on things like the graph search and hedge funds moving in from AAPL. I shorted FB yesterday but actual investors must be aware these stocks can go up based on momentum more than near-term profitability.]]>
      </content>
      <pubDate>Thu, 14 Feb 2013 09:05:13 -0500</pubDate>
      <description>
        <![CDATA[If you believe in these &quot;fundamental conversations&quot; why didn't you take a position in any of the stocks mentioned? FB doesn't just trade on earnings, there is a lot of speculation on things like the graph search and hedge funds moving in from AAPL. I shorted FB yesterday but actual investors must be aware these stocks can go up based on momentum more than near-term profitability.]]>
      </description>
    </item>
    <item>
      <title>2 Stocks To Buy, 2 Stocks To Sell</title>
      <link>http://seekingalpha.com/article/1178641/comments?source=feed#comment-14967821</link>
      <guid isPermaLink="false">14967821</guid>
      <content>
        <![CDATA[Vague advice on FB in this article. Will FB sink to it's 200 day MA while the executives get out at the top or will FB pop back above its 50 day MA soon once all the other hedge funds follow Cooperman? These are the sort of educated guesses we readers like to see.]]>
      </content>
      <pubDate>Thu, 14 Feb 2013 01:41:57 -0500</pubDate>
      <description>
        <![CDATA[Vague advice on FB in this article. Will FB sink to it's 200 day MA while the executives get out at the top or will FB pop back above its 50 day MA soon once all the other hedge funds follow Cooperman? These are the sort of educated guesses we readers like to see.]]>
      </description>
    </item>
    <item>
      <title>4 February 'Feel Good' Factors For Apple Fanatics</title>
      <link>http://seekingalpha.com/article/1151911/comments?source=feed#comment-14525001</link>
      <guid isPermaLink="false">14525001</guid>
      <content>
        <![CDATA[Every word any SA author writes on AAPL is suspect following the 2012 AAPL crash. Almost all SA articles failed to warn investors of the previous AAPL spikes below predicted &quot;bottoms.&quot; Traders may want to get in now, investors should wait until AAPL goes below $400 before even considering 1 share of this stock long-term.]]>
      </content>
      <pubDate>Sun, 03 Feb 2013 18:22:31 -0500</pubDate>
      <description>
        <![CDATA[Every word any SA author writes on AAPL is suspect following the 2012 AAPL crash. Almost all SA articles failed to warn investors of the previous AAPL spikes below predicted &quot;bottoms.&quot; Traders may want to get in now, investors should wait until AAPL goes below $400 before even considering 1 share of this stock long-term.]]>
      </description>
    </item>
    <item>
      <title>"Apple's (AAPL) glory days are now behind it," said FBN's Shebly Seyrafi on Thursday morning with the stock at $450. On Sept. 13 - the day after the iPhone 5 launch and the shares at $680 - Seyrafi reiterated a Buy rating and boosted his price target to $1,000. (FBN now maintains an Outperform on Apple with a lowered target of $650.)</title>
      <link>http://seekingalpha.com/currents/post/784471?source=feed#comment-14205221</link>
      <guid isPermaLink="false">14205221</guid>
      <content>
        <![CDATA[I disagree completely. Restating a bearish analyst sentiment on AAPL wouldn't be as relevant to investors now as quoting a bull-turned-bear analyst.]]>
      </content>
      <pubDate>Sat, 26 Jan 2013 19:23:32 -0500</pubDate>
      <description>
        <![CDATA[I disagree completely. Restating a bearish analyst sentiment on AAPL wouldn't be as relevant to investors now as quoting a bull-turned-bear analyst.]]>
      </description>
    </item>
    <item>
      <title>"Apple's (AAPL) glory days are now behind it," said FBN's Shebly Seyrafi on Thursday morning with the stock at $450. On Sept. 13 - the day after the iPhone 5 launch and the shares at $680 - Seyrafi reiterated a Buy rating and boosted his price target to $1,000. (FBN now maintains an Outperform on Apple with a lowered target of $650.)</title>
      <link>http://seekingalpha.com/currents/post/784471?source=feed#comment-14203821</link>
      <guid isPermaLink="false">14203821</guid>
      <content>
        <![CDATA[I'd like to see some accountability from some of the investment firms against their analysts who deceived the public with their projections. Peter Misek of Jefferies and Sheyrafi should be unemployed now. I suspect they're collecting bonuses rather than pink slips though.]]>
      </content>
      <pubDate>Sat, 26 Jan 2013 18:02:35 -0500</pubDate>
      <description>
        <![CDATA[I'd like to see some accountability from some of the investment firms against their analysts who deceived the public with their projections. Peter Misek of Jefferies and Sheyrafi should be unemployed now. I suspect they're collecting bonuses rather than pink slips though.]]>
      </description>
    </item>
  </channel>
</rss>
